New drugs and targets in haematological malignancies

Share :
Published: 10 Mar 2015
Views: 4037
Rating:
Save
Dr Renier Brentjens - Memorial Sloan Kettering Cancer Center, New York, USA

Dr Brentjens talks to ecancertv at TAT 2015 about chimeric antigen receptor (CAR) T cell therapy, outlining how it has been used with great success to treat patients with B-cell cancers.

He also discusses some of the practicalities and challenges of using this approach in clinical practice.